Antimutagenic effects and possible mechanisms of action of vitamins and related compounds against genotoxic heterocyclic amines from cooked food

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 444, Issue 1, 1999, Pages 235-248

  Edenharder, R ^a   Worf Wandelburg, A ^a   Decker, M ^a   Platt, K L ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Antimutagenicity; Cooked food mutagen; Mechanisms of antimutagenicity; Salmonella reversion assay; Vitamin

Indexed keywords

1,4 NAPHTHOQUINONE; 2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 2 AMINO 3,4 DIMETHYLIMIDAZO[4,5 F]QUINOLINE; 2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; ACETOMENAPHTHONE; ALPHA TOCOPHEROL; ANTIMUTAGENIC AGENT; ASCORBIC ACID; BETA CAROTENE; CYANOCOBALAMIN; FLAVONOID; FOLIC ACID; HETEROCYCLIC AMINE; MENADIONE; NICOTINAMIDE; NICOTINIC ACID; PANTOTHENIC ACID; PHYTOMENADIONE; PYRIDOXAL; PYRIDOXAMINE; PYRIDOXINE; RETINAL; RETINOIC ACID; RETINOID; RETINOL; UBIDECARENONE; UNINDEXED DRUG; VITAMIN; VITAMIN K GROUP;

AMES TEST; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; FOOD; GENOTOXICITY; METABOLIC ACTIVATION; MUTAGENIC ACTIVITY; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTIMUTAGENIC AGENTS; BIOTRANSFORMATION; FLAVIN-ADENINE DINUCLEOTIDE; FOOD ANALYSIS; FOOD CONTAMINATION; HEAT; MALE; MICROSOMES, LIVER; MUTAGENICITY TESTS; MUTAGENS; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; SALMONELLA TYPHIMURIUM; VITAMIN A; VITAMIN K; VITAMINS;

SALMONELLA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0032780490     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00098-4     Document Type: Article

References (60)

1. Layton D.W., Bogen K.T., Knize M.G., Hatch F.T., Johnson V.M., Felton J.S. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis. 16:1995;39-52.
2. Ohgaki H., Takayama S., Sugimura T. Carcinogenicities of heterocyclic amines in cooked food. Mutat. Res. 259:1991;399-410.
3. IARC Some naturally occurring and synthetic food components, furocoumarins and ultraviolet radiation. IARC Monogr. 40:1986;223-228.
4. Sugimura T. Studies on environmental chemical carcinogenesis in Japan. Science. 233:1986;312-318.
5. Felton J.S., Knize M.G. Occurrence, identification, and bacterial mutagenicity of heterocyclic amines in cooked food. Mutat. Res. 259:1991;205-217.
6. Hatch F.T., Knize M.G., Moore D.H. II, Felton J.S. Quantitative correlation of mutagenic and carcinogenic potencies for heterocyclic amines from cooked foods and additional aromatic amines. Mutat. Res. 271:1992;269-287.
7. Skog K. Cooking procedures and food mutagens: a literature review. Food Chem. Toxicol. 31:1993;655-675.
8. Steinmetz K.A., Potter J.D. Vegetables, fruit and cancer: I. Epidemiology. Cancer Causes Control. 2:1991;325-357.
9. Block G., Patterson B., Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer. 18:1992;1-29.
10. Ames B.N. Dietary carcinogens and anticarcinogens. Science. 221:1983;1256-1264.
11. Ramel C., Alekperov U.K., Ames B.N., Kada T., Wattenberg I.W. Inhibitors of mutagenesis and their relevance to carcinogenesis. Report by ICEM expert group on antimutagens and desmutagens. Mutat. Res. 168:1986;47-65.
12. de Flora S., Ramel C. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview. Mutat. Res. 202:1988;285-306.
13. Steinmetz K.A., Potter J.D. Vegetables, fruit and cancer: II. Mechanisms. Cancer Causes Control. 2:1991;427-442.
14. Hayatsu H., Arimoto S., Negishi T. Dietary inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 202:1988;429-446.
15. Hartman P., Shankel D.M. Antimutagens and anticarcinogens: a survey of putative interceptor molecules. Environ. Mol. Mutagen. 15:1990;145-182.
16. Odin A.W. Vitamins as antimutagens: advantages and some possible mechanisms of antimutagenic action. Mutat. Res. 386:1997;39-67.
17. Edenharder R., Kurz P., John K., Burgard S., Seeger K. In vitro effect of vegetable and fruit juices on the mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline, 2-amino-3,4-dimethyl-imidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoline. Food Chem. Toxicol. 32:1994;443-459.
18. Edenharder R., Leopold Ch., Kries M. Modifying actions of solvent extracts from fruit and vegetable residues on 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) induced mutagenesis in Salmonella typhimurium. Mutat. Res. 341:1995;303-318.
19. Edenharder R., von Petersdorff I., Rauscher R. Antimutagenic effects of flavonoids, chalcones and structurally related compounds on the activity of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and other heterocyclic amine mutagens from cooked food. Mutat. Res. 287:1993;261-274.
20. Edenharder R., Rauscher R., Platt K.L. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study. Mutat. Res. 379:1997;21-32.
21. Edenharder R., Speth C., Decker M., Koldziej H., Kayser O., Platt K.L. Inhibition of mutagenesis of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) by coumarins and furanocoumarins, chromanones and furanochromanones. Mutat. Res. 345:1995;57-71.
22. Edenharder R., Speth C., Decker M., Platt K.L. The inhibition by naphtoquinones and anthraquinones of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study. Z. Lebensm.-Unters. Forsch. A. 207:1998;464-471.
23. Mayer R.T., Jermyn J.W., Burke M.D., Prough R.A. Methoxyresorufin as a substrate for the fluorimetric assay of insect microsomal O-dealkylases. Pestic. Biochem. Biol. 7:1977;349-354.
24. Ong T.-M., Mukhtar M., Wolf C.R., Zeiger E. Differential effects of cytochrome P-450 inducers on promutagen activation capabilities and enzyme activities of S9 from rat liver. J. Environ. Pathol. Toxicol. 4:1980;55-65.
25. Elliott B.M., Combes R.D., Elcombe C.R., Gatehouse D.G., Gibson G.G., Mackay J.M., Wolf R.C. Report of UK environmental mutagen society working party. Alternatives to Aroclor 1254-induced S9 in in vitro genotoxicity assays. Mutagenesis. 7:1992;175-177.
26. Maron D.M., Ames B.N. Revised methods for Salmonella mutagencity test. Mutat. Res. 113:1983;173-215.
27. de Flora S., Camoirano A., d'Agostini F., Balansky R. Modulation of the mutagenic response in prokaryotes. Mutat. Res. 267:1992;183-192.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
29. Waleh N.S., Rapport S.J., Mortelmans K. Development of a toxicity test to be coupled to the Ames Salmonella assay and the method of construction of the required strains. Mutat. Res. 97:1982;247-256.
30. Pederson T.C., Buege J.A., Aust S.D. Microsomal electron transport: the role of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase in liver microsomal lipid peroxidation. J. Biol. Chem. 248:1973;7134-7141.
31. Burke M.D., Mayer R.T. Ethoxyresorufin: direct fluorometric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab. Dispos. 2:1974;583-588.
32. Terwel L., van der Hoeven J.C.M. Antimutagenic activity of some naturally occurring compounds towards cigarette-smoke condensate and benzo[a]pyrene in the Salmonella/microsome assay. Mutat. Res. 152:1985;1-4.
33. 1: in vitro effects of vitamins. Mutat. Res. 188:1987;121-128.
34. Ejchart A., Chlopkiewicz B., Czarnomska A., Koziorowska J. Effects of riboflavin on benzo[a]pyrene, 2-acetylaminofluorene, and methyl-methanesulfonate mutagenicity in vitro. Pol. J. Pharmacol. Pharm. 42:1990;159-164.
35. Wood A.W., Sayer J.M., Newmark H.L., Yagi H., Michaud D.P., Jerina D.M., Conney A.H. Mechanism of the inhibition of mutagenicity of a benzo[a]pyrene 7,8-diol 9,10-epoxide by riboflavin 5′-phosphate. Proc. Natl. Acad. Sci. U.S.A. 79:1982;5122-5126.
36. Shetty T.K., Francis A.R., Bhattacharya R.K. Modifying role of vitamins on the mutagenic action of N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis. 9:1988;1513-1515.
37. 1. Carcinogenesis. 5:1984;1359-1362.
38. Tang X., Edenharder R. Inhibition of the mutagenicity of 2-nitrofluorene, 3-nitrofluoranthene and 1-nitropyrene by vitamins, porphyrins and related compounds, and vegetable and fruit juices and solvent extracts. Food Chem. Toxicol. 35:1997;373-378.
39. Israels L.G., Walls G.A., Ollmann D.J., Friesen E., Israels E.D. Vitamin K as a regulator of benzo[a]pyrene metabolism, mutagenesis and carcinogenesis. J. Clin. Invest. 71:1983;1130-1140.
40. Kushi A., Koiwai A., Yoshida D., Goto F. Effect of emodin on the mutagenicity of 3-amino-1-methyl-5H-pyrido[4,3-b]indole toward Salmonella. Agric. Biol. Chem. 44:1980;2513-2515.
41. Hao N.J., Huang M.P., Lee H. Structure-activity relationship of anthraquinones as inhibitors of 7-ethoxycoumarin-O-deethylase and mutagenicity of 2-amino-3-methylimidazo-[4,5-f]quinoline. Mutat. Res. 328:1995;183-191.
42. Sadowski J.A., Esmon C.T., Suttie J.W. Vitamin K-dependent carboxylase: requirements of the rat liver microsomal enzyme system. J. Biol. Chem. 251:1976;2770-2776.
43. Rahimtula A.D., Zachariah P.K., O'Brien P.J. The effects of antioxidants on the metabolism and mutagenicity of benzo[a]pyrene in vitro. Biochem. J. 164:1977;473-475.
44. Brockman H.E., Stack H.F., Waters M.D. Antimutagenicity profiles of some natural substances. Mutat. Res. 267:1992;157-172.
45. Ioannides C., Ayrton A.D., Keele A., Lewis D.F.V., Flatt P.R., Walker R. Mechanism of the in vitro antimutagenic action of retinol. Mutagenesis. 5:1990;257-262.
46. Busk L., Ahlborg U.G., Albanus L. Inhibition of protein pyrolysate mutagenicity by retinol (vitamin A). Food Chem. Toxicol. 20:1982;535-539.
47. Okai Y., Higashi-Okai K., Nakamura S., Yano Y., Otani S. Suppressive effects of retinoids, carotenoids and antioxidant vitamins on heterocyclic amine-induced umu C gene expression in Salmonella typhimurium (TA 1535/pSK 1002). Mutat. Res. 368:1996;133-140.
48. Baird M.B., Birnbaum L.S. Inhibition of 2-fluorenamine induced mutagenesis in Salmonella typhimurium by vitamin A. J. Natl. Cancer Inst. 63:1979;1093-1096.
49. Busk L., Ahlborg U.G. Retinol (vitamin A) as a modifier of 2-aminofluorene and 2-acetylaminofluorene mutagenesis in the Salmonella/microsome assay. Arch. Toxicol. 49:1982;169-174.
50. Balbinder E., Stick S.M., Sharma O.K. Complex effects of retinol on the metabolic activation of 2-aminofluorene. Environ. Mutagen. 5:1983;665-678.
51. Busk L., Sjostrom B., Ahlborg U.G. Effects of vitamin A on cyclophosphamide mutagenicity in vitro (Ames test) and in vivo (mouse micronucleus test). Food Chem. Toxicol. 22:1984;725-730.
52. Busk L., Ahlborg U.G. Retinoids as inhibitors of ortho-aminoazotoluene-induced mutagenesis in the Salmonella/liver microsome test. Mutat. Res. 104:1982;225-231.
53. 1-induced reversion in Salmonella typhimurium TA 98. Teratog., Carcinog., Mutagen. 8:1988;215-224.
54. 1-induced mutagenesis in S. typhimurium TA 100 and TA 98. Nutr. Cancer. 13:1990;243-253.
55. Azuine M.A., Goswami U.C., Kayal J.J., Bhide S.V. Antimutagenic and anticarcinogenic effects of carotenoids and dietary palm oil. Nutr. Cancer. 17:1992;287-295.
56. Santamaria L., Bianchi L., Bianchi A., Pizzala R., Santagati G., Bermond P. Photomutagenicity by 8-methoxypsoralen with and without singlet oxygen involvement and its prevention by beta-carotene. Relevance to the mechanism of 8-MOP photocarcinogenicity and to PUVA application. Med. Biol. Environ. 12:1984;541-546.
57. Belisario M.A., Pecce R., Battista C., Panza N., Pacilio G. Inhibition of cyclophosphamide mutagenicity by β-carotene. Biomed. Pharmacother. 39:1985;445-448.
58. Rauscher R., Edenharder R., Platt K.L. In vitro antimutagenic and in vivo anticlastogenic effects of carotenoids and solvent extracts from fruits and vegetables rich in carotenoids. Mutat. Res. 413:1998;129-142.
59. de Flora S., Bennicelli C., d'Agostini F., Izzotti A., Camoirano A. Cytosolic activation of aromatic and heterocyclic amines. Inhibition by dicoumarol and enhancement in viral hepatitis B. Environ. Health Perspect. 102:1994;69-74. Suppl. 6.
60. Waters M.D., Stack H.F., Jackson M.A., Brockman H.E., de Flora S. Activity profiles of antimutagens: in vitro and in vivo data. Mutat. Res. 350:1996;109-129.